期刊文献+

重症监护病房革兰阴性杆菌对常用抗菌药物体外抗菌活性研究 被引量:4

In Vitro Activity of Gram-negative Bacilli in Intensive Care Units to Commonly Used Drug
暂未订购
导出
摘要 目的:了解重症监护病房革兰阴性杆苗的分布及常用治疗中重度感染的抗菌药物对其的敏感性,指导临床用药。方法:采用浓度梯度法共测定11种抗菌药物对303株革兰阴性杆菌的体外抗菌活性。结果:在重症观察病房中革兰阴性杆菌常见病原菌为铜绿假单胞菌(29.7%)、大肠埃希菌(19.1%)、肺炎克雷伯菌(15.2%)、不动杆菌(8.6%)、嗜麦芽窄食单胞菌(6.9%)和阴沟肠杆菌(6.9%)。治疗铜绿假单胞菌感染的常用药物的敏感性同国内其他文献比较有一定程度下降。31%(18/58)的大肠埃希菌和15%(7/46)的肺炎克雷伯菌证实产ESBLs,ESBL菌合计的阳性率为24%。四代头孢菌素对于肠杆菌科细菌的敏感覆盖率较高于三代头孢菌素。对嗜麦芽窄食单胞菌敏感覆盖率较高的抗菌药是替卡西林/克拉维酸(95.2%)和头孢派酮/舒巴坦(90.2%)。对不动杆菌敏感覆盖率较高的抗菌药是亚胺培南(100%)和头孢哌酮/舒巴坦(61.5%)。结论:定期进行细菌耐药性的监测,有助于合理应用抗菌药物。 OBJECTIVE: To investigate the distribution and drug resistance of gram-negative bacilli in intensive care units. METHODS: 303 clinical isolates were tested in vitro susceptibility by Etest. RESULTS: The common bacteria in intensive care units were Pseudomonas aeruginosa (29.7%), Escherichia col i (1 9.1 %), Klebsiella pneumoniae( 1 5.2 %), Acinetobacter spp (8.6%), Stenophotomonas maltophilus (6.9%) and Enterobacter cloacae (6.9%). The susceptiveness of commonly used drug to Pseudonas aeruginosa were lower than other paper reported. The ESBL postive rate of Escherichia coli was 31% , Klebsiella pneumoniae was 15%, the total ESBL positive rate was 24% in the test. The fourth cephalosporin was more sensitive to Enterobacter than the third cephalosporin. The high susceptiveness of Stenophotomonas maltophilus were ticarcillin/clavulanic acid (95.2%) and cefoperazone/sulbactam (90.2%). The high susceptiveness of Acinetobacter spp. were imipenem (100%) and cefoperazone/sulbactam (61.5%). CONCLUSION: Monitoring the drug resistance of bacteria regular is helpful to application antibacterial reasonable.
机构地区 卫生部北京医院
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2002年第3期177-181,共5页 The Chinese Journal of Clinical Pharmacology
关键词 重症监护病房 革兰阴性杆菌 抗菌药 体外抗菌活性 耐药性 医院感染 gram-negative bacilli drug resistance nosocomial infections
  • 相关文献

参考文献5

二级参考文献35

共引文献824

同被引文献24

  • 1黄娟,谢志春.不动杆菌属耐药机制研究进展[J].广西预防医学,2004,10(4):253-254. 被引量:4
  • 2李家泰,齐慧敏,李耘,代表中国细菌耐药监测研究组.2002—2003年中国医院和社区获得性感染革兰阳性细菌耐药监测研究[J].中华检验医学杂志,2005,28(3):254-265. 被引量:225
  • 3梁小英.74株鲍曼不动杆菌的耐药性分析[J].广西医学,2005,27(4):523-524. 被引量:4
  • 4颜青,肖永红,何绥平.必须重视β内酰胺类抗生素与其酶抑制剂复方制剂的科学开发[J].中国临床药学杂志,2007,16(4):259-261. 被引量:9
  • 5Schito GC, Pesce A, Debbia EA. 1-Stability in the presence of widespread beta-lactamases. A prerequisite for the antibacterial activity of beta-lactam drugs[J]. Drugs, 1994;47( Suppl. 3) :S1- S8.
  • 6Odenhoh-Tomqvist I, Lowdin E, Cars O. Pharmacodynamic effects of subinhibitory concentrations of beta-lactam antibiotics in vitro[ J 1. Antimicrob Agents Chemother, 1991 ;35 : 1834-1839.
  • 7Fantin B, Pangon B, Potel G, et al. Activity of sulbactam in combination with ceftriaxone /n v/tro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like β-lactamase [ J ]. Antimicrob Agents Chemother, 1990 ;34:581-586.
  • 8Buijk SL, Gyssens IC, Mouton JW, et al. Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdomi- nal infections[ J]. J Antimicrob Chemother, 2002 ; 49 : 121-128.
  • 9Tumidge JD. The pharmacodyrlamics of beta-lactams[J]. Clin Infect Dis,1998; 27:10-22.
  • 10Pedeboscq S, Dubau B, Frappier S, et al. Comparison of 2 administration protocols ( continuous or discontinuous ) of a timedependent antibiotic[J]. Tazocin Pathol Biol, 2001 ; 49 : 540-547.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部